MAM
ABBV icon

Madison Asset Management’s AbbVie ABBV Stock Holding History

Madison Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20M Buy
79,651
+19,282
+32% +$4.15M 0.24% 100
2026
Q1 		$13.1M Sell
60,369
-5,052
-8% -$1.12M 0.16% 118
2025
Q4 		$14.9M Sell
65,421
-1,980
-3% -$451K 0.17% 109
2025
Q3 		$15.6M Sell
67,401
-2,791
-4% -$568K 0.17% 110
2025
Q2 		$13M Sell
70,192
-9,078
-11% -$1.69M 0.14% 117
2025
Q1 		$16.6M Sell
79,270
-4,957
-6% -$964K 0.19% 106
2024
Q4 		$15M Sell
84,227
-6,530
-7% -$1.2M 0.17% 109
2024
Q3 		$17.9M Sell
90,757
-2,951
-3% -$551K 0.2% 109
2024
Q2 		$16.1M Buy
93,708
+71,776
+327% +$11.9M 0.2% 106
2024
Q1 		$3.99M Buy
21,932
+6,715
+44% +$1.16M 0.05% 199
2023
Q4 		$2.36M Buy
15,217
+6,120
+67% +$892K 0.03% 245
2023
Q3 		$1.36M Buy
+9,097
New +$1.34M 0.02% 271
2023
Q1 		– Sell
-2,906
Closed -$470K – 300
2022
Q4 		$470K Sell
2,906
-176
-6% -$27K 0.01% 290
2022
Q3 		$414K Sell
3,082
-77
-2% -$11K 0.01% 308
2022
Q2 		$484K Sell
3,159
-259
-8% -$39.6K 0.01% 318
2022
Q1 		$554K Sell
3,418
-265
-7% -$38.5K 0.01% 273
2021
Q4 		$499K Sell
3,683
-6,988
-65% -$825K 0.01% 289
2021
Q3 		$1.15M Buy
10,671
+837
+9% +$95.6K 0.02% 260
2021
Q2 		$1.11M Buy
9,834
+726
+8% +$81.8K 0.01% 266
2021
Q1 		$986K Sell
9,108
-497
-5% -$53.2K 0.01% 262
2020
Q4 		$1.03M Hold
9,605
– – 0.02% 254
2020
Q3 		$841K Hold
9,605
– – 0.01% 227
2020
Q2 		$943K Buy
9,605
+5,555
+137% +$489K 0.02% 228
2020
Q1 		$309K Buy
+4,050
New +$345K 0.01% 249

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Madison Asset Management's ABBV Position: Q2 2026 in Review

Madison Asset Management increased its AbbVie (ABBV) stake by 32% in Q2 2026, buying an estimated $4.15M and bringing the position to 79,651 shares worth $20M. The position accounts for 0.24% of the portfolio, ranked #100.

Madison Asset Management first reported a position in ABBV in Q1 2020 and has held it in 24 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Madison Asset Management held 79,651 shares of AbbVie worth $20M as of Q2 2026.
  • Madison Asset Management bought 19,282 AbbVie shares in Q2 2026, an estimated $4.15M.
  • AbbVie made up 0.24% of Madison Asset Management's portfolio in Q2 2026, its #100 holding.
  • Madison Asset Management first reported a position in AbbVie in Q1 2020 and has held it in 24 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Madison Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.